Brasada Capital Management LP purchased a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 2,526 shares of the conglomerate’s stock, valued at approximately $1,819,000.
A number of other institutional investors have also modified their holdings of DHR. FSA Advisors Inc. purchased a new stake in shares of Danaher in the 2nd quarter valued at $269,000. N10 Assets LLC purchased a new position in Danaher during the 2nd quarter valued at about $7,208,000. Coastal Bridge Advisors LLC purchased a new position in Danaher during the 2nd quarter valued at about $490,000. Jefferies Financial Group Inc. acquired a new position in Danaher in the 2nd quarter valued at about $1,586,000. Finally, Public Employees Retirement System of Ohio purchased a new stake in Danaher during the second quarter worth about $41,194,000. 79.05% of the stock is owned by institutional investors and hedge funds.
Danaher Price Performance
DHR stock opened at $215.74 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The firm has a market capitalization of $151.67 billion, a P/E ratio of 38.32, a P/E/G ratio of 2.68 and a beta of 0.78. The business’s 50-day moving average is $198.69 and its two-hundred day moving average is $192.35. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.
Analyst Ratings Changes
DHR has been the topic of several research reports. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. HSBC dropped their price objective on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. DZ Bank assumed coverage on shares of Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 target price on the stock. Citigroup assumed coverage on shares of Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $240.00 price target on shares of Danaher in a research report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $228.91.
View Our Latest Stock Analysis on Danaher
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
